Related Experiment Video
Updated: Jan 20, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
Ruxolitinib is an effective steroid sparing agent in bronchiolitis obliterans due to chronic
Christopher Streiler1, Faizan Shaikh2, Christian Davis3
1Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kansas, 3901 Rainbow Blvd. MS 3007, Kansas City, KS, USA. cstreiler@kumc.edu.
No abstract available in PubMed .
More Related Videos
Related Concept Videos
09:00High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
05:54Induction of Graft Versus Host Disease in Mouse Models via Allogeneic Bone Marrow and Splenic Cell Transplantation
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
09:50Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
09:33Scalable, Flexible, and Cost-Effective Seedling Grafting
08:50Establishment and Evaluation of a Porcine Vein Graft Disease Model

